NEW YORK, March 10, 2021 (GLOBE NEWSWIRE)
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief Executive Officer will present a corporate update at the
Inaugural Emerging Growth Virtual Conference, held by M Vest LLC and Maxim Group LLC. The conference will take place on March 17th - 19th from 9:00 AM to 5:00 PM EDT.
During this virtual conference, the Company will present along with other important voices in the healthcare sector. The conference will feature roundtable discussions, issuer presentations, fireside chats, and live Q&A with company CEOs moderated by Maxim research analysts. To attend and access conference content, sign up to become an M-Vest member for more updates HERE.
PAVmed Announces Closing of its Public Offering of Common Stock
02/25/2021 | 01:38pm EDT
Send by mail :
Message :
NEW YORK, Feb. 25, 2021 (GLOBE NEWSWIRE)
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today announced the closing of its previously announced underwritten public offering (the “Offering”) of approximately 9.8 million shares of its common stock for gross proceeds of approximately $45 million, before deducting underwriting discounts and commissions and other offering expenses payable by PAVmed.
Cantor Fitzgerald & Co. acted as sole bookrunner for the Offering. Lake Street Capital Markets LLC and Maxim Group LLC acted as financial advisors to the Company.
PAVmed Provides Business Update and Preliminary Fourth Quarter 2020 Financial Results forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
PAVmed Reschedules Business Update Conference Call on February 22, 2021 to 8:30 AM EST
Conference call and live webcast was previously scheduled for 4:30 PM EST
Lucid Diagnostics strategic advisor and medical diagnostics pioneer Stanley Lapidus to join call
NEW YORK, Feb. 18, 2021 (GLOBE NEWSWIRE)
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today announced that the Company has moved the time of its business update conference call on Monday, February 22, 2021 to 8:30 AM EST to accommodate the schedule of PAVmed subsidiary Lucid Diagnostics Inc’s (“Lucid”) Strategic Advisor, medical diagnostics pioneer Stanley Lapidus.
Mr. Lapidus will join PAVmed Chairman and Chief Executive Officer Lishan Aklog, M.D., and President and Chief Financial Officer Dennis McGrath on the call. Mr. McGrath will provide a financial update on the Company. Dr. Aklog will provide a business u
Share:
NEW YORK, Feb. 16, 2021 (GLOBE NEWSWIRE)
PAVmed Inc. (NASDAQ:PAVM, PAVMZ)) (the Company or PAVmed ), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that the first U.S. patient recently underwent successful carpal tunnel release using its CarpX
® minimally invasive carpal tunnel device.
CarpX relieves the symptoms of Carpal Tunnel Syndrome (CTS) in a rapid, minimally invasive, office-based procedure that speeds patients recovery. CTS is a common workplace-related condition that causes chronic pain to patients and, as the top driver of workmen s compensation claims, imposes high costs on society.
The patient presented with symptoms of carpal tunnel syndrome to Dr. Edward J. Armbruster of Mercer-Bucks Orthopaedics, P.C., in greater Philadelphia, who performed minimally invasive carpal tunnel release using the CarpX device. In marked contrast to typical recovery times of up to several months following conventiona